EvolveImmune Therapeutics Employee Directory
Biotechnology ResearchConnecticut, United States51-200 Employees
EvolveImmune Therapeutics is a biotechnology research company focused on cancer immunotherapy. It is developing trispecific T cell engagers with integrated CD2 costimulation to address cancer cell resistance to current treatments. Based in Branford, Connecticut, the company operates as a mid-sized enterprise in the oncology-focused biotech space. Its lead internal candidate, EVOLVE104, is planned to enter the clinic in 2025. In late 2024, EvolveImmune began a collaboration with AbbVie to develop multispecific biologics for oncology, a partnership that has progressed with activity including a development candidate nomination under the arrangement. The company has presented progress on its EVOLVE T cell engager platform at major conferences, including the 2026 AACR Annual Meeting.